Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gower

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature Communications|February 17, 2021
Biological and therapeutic implications of a unique subtype of NPM1 mutated AMLArvind Singh Mer, Emily M Heath, Seyed Ali Madani Tonekaboni, et al.
Science Translational Medicine|January 1, 2025
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroupMark Gower, Ximing Li, Alicia G Aguilar-Navarro, et al.
Blood|April 20, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based ChemotherapyXiming Li, Alicia G Aguilar-Navarro, Mursal Nader, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature Communications|February 17, 2021
Biological and therapeutic implications of a unique subtype of NPM1 mutated AMLArvind Singh Mer, Emily M Heath, Seyed Ali Madani Tonekaboni, et al.
Science Translational Medicine|January 1, 2025
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroupMark Gower, Ximing Li, Alicia G Aguilar-Navarro, et al.
Blood|April 20, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based ChemotherapyXiming Li, Alicia G Aguilar-Navarro, Mursal Nader, et al.
Pageof 1